October Pharma results, Fiscal year 2025
Net profit, assets, equity and cash flow for Fiscal year 2025, against the same period a year earlier, from the published financial statements. The figures cover the 12 months to 31 December 2025; the comparison is with the same months a year earlier, from the same disclosure.
In short
- October Pharma's net profit for Fiscal year 2025 was about 206 million EGP, up +35.5% from 152 million EGP in Fiscal year 2024.
Key lines against the same period a year earlier
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. The figures cover the 12 months to 31 December 2025; the comparison is with the same months a year earlier, from the same disclosure.
October Pharma's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy